Kamran, Sophia C <br/><br/>
Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.  [electronic resource] 

 -  Leukemia & lymphoma  06 2018 
 - 1384-1390 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2017.1376745  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--adverse effects<br/>Chemoradiotherapy<br/>Dacarbazine--adverse effects<br/>Doxorubicin--adverse effects<br/>Female<br/>Fluorodeoxyglucose F18<br/>Hodgkin Disease--diagnosis<br/>Humans<br/>In Vivo Dosimetry<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Positron Emission Tomography Computed Tomography<br/>Radiation Dosage<br/>Radiotherapy, Adjuvant--methods<br/>Treatment Outcome<br/>Vinblastine--adverse effects<br/>Young Adult